The use of intravenous immune globulin in immunodeficiency diseases
- PMID: 2052044
- DOI: 10.1056/NEJM199107113250207
The use of intravenous immune globulin in immunodeficiency diseases
Similar articles
-
Intravenous immune globulin therapy for antibody immunodeficiency.Clin Ther. 1984;7(1):69-72. Clin Ther. 1984. PMID: 6518465
-
Mechanisms and uses of intravenous immune globulin in primary ond secondary immune deficiency disorders. Naples, Florida, October 13-14, 1988.J Allergy Clin Immunol. 1989 Oct;84(4 Pt 2):565-648. J Allergy Clin Immunol. 1989. PMID: 2794300 No abstract available.
-
New uses of intravenous immune globulin therapy.West J Med. 1991 Apr;154(4):461. West J Med. 1991. PMID: 1877192 Free PMC article. No abstract available.
-
Intravenous therapy with gamma globulin.Adv Intern Med. 1987;32:111-35. Adv Intern Med. 1987. PMID: 3548246 Review.
-
Intravenous immunoglobulin: a review.Immunodefic Rev. 1989;1 Suppl:1-42. Immunodefic Rev. 1989. PMID: 2698646 Review.
Cited by
-
Intravenous immunoglobulin in dermatology.Indian J Dermatol. 2009;54(1):77-9. doi: 10.4103/0019-5154.48996. Indian J Dermatol. 2009. PMID: 20049279 Free PMC article. No abstract available.
-
Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates.J Clin Immunol. 2010 May;30(3):442-8. doi: 10.1007/s10875-010-9373-x. Epub 2010 Mar 10. J Clin Immunol. 2010. PMID: 20217199 Clinical Trial.
-
Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center.J Clin Immunol. 2009 May;29(3):357-64. doi: 10.1007/s10875-008-9273-5. Epub 2009 Jan 28. J Clin Immunol. 2009. PMID: 19184381 Free PMC article.
-
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.J Clin Immunol. 2022 Apr;42(3):500-511. doi: 10.1007/s10875-021-01181-6. Epub 2022 Jan 1. J Clin Immunol. 2022. PMID: 34973143 Free PMC article.
-
Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.Vaccines (Basel). 2021 Jun 21;9(6):680. doi: 10.3390/vaccines9060680. Vaccines (Basel). 2021. PMID: 34205517 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical